ALLIGATOR BIOSCIENCE

Alligator is a research-based biotechnology company developing antibody-based pharmaceuticals for cancer treatment. The company specializes in the development of tumor-directed immunotherapies, in particular agonistic mono- and bispecific antibodies. In immunotherapy, the patients´ immune system is activated to cure cancer. The term tumor-directed means that the drug is administered or designed such that the pharmacological effect is localized to the tumor. This results in an advantageous efficacy and safety profile.

Also known as: Alligator, Alligator Bioscience AB

Registration numbers: 5565978201 (W)

Primary location: Lund Sweden